Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms Louvre 3
- Sponsors Allergan
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 20 Jul 2017 Planned End Date changed from 1 Sep 2019 to 15 Apr 2020.
- 20 Jul 2017 Planned primary completion date changed from 1 Sep 2019 to 15 Apr 2020.